Home > Products > Biosimilars

BioSIM anti-Human RANKL Antibody (Denosumab Biosimilar), Research Grade

Catalog: SIM0037
Cost advantage to: SIM0028
Isotype: IgG2-kappa
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic Denosumab biosimilar, sharing the same variable regions as the therapeutic version, suits research use. It binds human RANKL (also CD254/TRANCE, a 35 kDa TNF superfamily type II membrane protein) expressed on activated T lymphocytes (lung, thymus, lymph nodes) and osteoclasts. RANKL regulates T cell-dendritic cell interactions and is key for osteoclast differentiation; Denosumab inhibits RANKL to reduce osteoclast development.
 

Specifications

Product Name BioSIM anti-Human RANKL Antibody (Denosumab Biosimilar), Research Grade
Size 1mg/5mg
Isotype IgG2-kappa
Target RANKL
Other Names AMG162, CAS: 615258-40-7
CAS 615258-40-7
Reactivity Human
Host Species Human
Background This non-therapeutic Denosumab biosimilar, sharing the same variable regions as the therapeutic version, suits research use. It binds human RANKL (also CD254/TRANCE, a 35 kDa TNF superfamily type II membrane protein) expressed on activated T lymphocytes (lung, thymus, lymph nodes) and osteoclasts. RANKL regulates T cell-dendritic cell interactions and is key for osteoclast differentiation; Denosumab inhibits RANKL to reduce osteoclast development.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products